Sharona B. Ross
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sharona B. Ross has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Iswanto Sucandy
Digestive Health Institute AdventHealth Tampa, Tampa, USA
19 shared publicationsMaria Christodoulou
Foregut and HPB Division, Digestive Health Institute Advent Health Tampa, Tampa, USA
18 shared publicationsAlexander Rosemurgy
Foregut and HPB Division, Digestive Health Institute AdventHealth Tampa, Tampa, USA
13 shared publications- Alexander Rosemurgy
Florida Hospital Tampa, Tampa, FL
10 shared publications - Iswanto Sucandy
Advent Health Tampa, Digestive Health Institute, Tampa, USA
9 shared publications Tara M. Pattilachan
Foregut and HPB Division, Digestive Health Institute Advent Health Tampa, Tampa, USA
9 shared publications
Latest Publications
- 25 September 2026
- Published by Springer Nature in Surgical Endoscopy
- p. 1-8
Is robotic surgery meeting nodal benchmarks? AJCC and NCCN-based evaluation of lymph node yield and survival in robotic transhiatal esophagectomy
Background Adequate lymph node (LN) retrieval is a key determinant of staging quality in esophageal cancer, with current guidelines recommending evaluation of at least 15 nodes. However, the relevance of this threshold in robotic transhiatal esophagectomy (THE) remains unclear. Methods We performed a retrospective analysis of a prospectively maintained single-center cohort of patients undergoing robotic THE for esophagogastric junction adenocarcinoma (2012–2024). Patients were stratified by LN yield (< 15 vs ≥ 15) according to AJCC and NCCN. Clinicopathologic variables, perioperative outcomes, disease-free survival (DFS), and overall survival (OS) were compared. Survival was assessed using Kaplan–Meier analysis. Results Eighty-four patients were included, with 56 (66.7%) in the < 15 LN group and 28 (33.3%) in the ≥ 15 LN group. Baseline characteristics were comparable. Higher LN yield was associated with increased lymphovascular invasion (32.1% vs 9.0%, p = 0.012) and a trend toward higher nodal positivity (50.0% vs 30.4%, p = 0.079). Perioperative outcomes, including complications and mortality, were similar between groups. Median follow-up was 47.8 months. Median DFS was 33.6 months in the < 15 LN group and 97.9 months in the ≥ 15 LN group (p = 0.430), while median OS was not reached and 97.9 months, respectively (p = 0.555). At 3 years, DFS (65% vs 49%) and OS (75% vs 56%) were numerically higher in the ≥ 15 LN group. Conclusions Retrieval of ≥ 15 lymph nodes during robotic THE is associated with improved pathologic characterization without increasing perioperative morbidity. Although survival differences were not statistically significant, higher LN yield demonstrated a consistent trend toward improved outcomes, supporting its role as a quality metric in robotic esophagectomy.
- 25 September 2026
- Published by Springer Nature in Surgical Endoscopy
- p. 1-8
Is robotic surgery meeting nodal benchmarks? AJCC and NCCN-based evaluation of lymph node yield and survival in robotic transhiatal esophagectomy
Background Adequate lymph node (LN) retrieval is a key determinant of staging quality in esophageal cancer, with current guidelines recommending evaluation of at least 15 nodes. However, the relevance of this threshold in robotic transhiatal esophagectomy (THE) remains unclear. Methods We performed a retrospective analysis of a prospectively maintained single-center cohort of patients undergoing robotic THE for esophagogastric junction adenocarcinoma (2012–2024). Patients were stratified by LN yield (< 15 vs ≥ 15) according to AJCC and NCCN. Clinicopathologic variables, perioperative outcomes, disease-free survival (DFS), and overall survival (OS) were compared. Survival was assessed using Kaplan–Meier analysis. Results Eighty-four patients were included, with 56 (66.7%) in the < 15 LN group and 28 (33.3%) in the ≥ 15 LN group. Baseline characteristics were comparable. Higher LN yield was associated with increased lymphovascular invasion (32.1% vs 9.0%, p = 0.012) and a trend toward higher nodal positivity (50.0% vs 30.4%, p = 0.079). Perioperative outcomes, including complications and mortality, were similar between groups. Median follow-up was 47.8 months. Median DFS was 33.6 months in the < 15 LN group and 97.9 months in the ≥ 15 LN group (p = 0.430), while median OS was not reached and 97.9 months, respectively (p = 0.555). At 3 years, DFS (65% vs 49%) and OS (75% vs 56%) were numerically higher in the ≥ 15 LN group. Conclusions Retrieval of ≥ 15 lymph nodes during robotic THE is associated with improved pathologic characterization without increasing perioperative morbidity. Although survival differences were not statistically significant, higher LN yield demonstrated a consistent trend toward improved outcomes, supporting its role as a quality metric in robotic esophagectomy.
- 4 June 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (8) , 6577-6584
A prospective, single-center investigation of the single-port robotic platform for cholecystectomy, gastrectomy and anti-reflux operations
Single-port (SP) robotic operations are the next frontier of minimally invasive surgery (MIS), promising to build upon multi-port robotic and laparoscopic techniques. This study aimed to assess the safety and feasibility of SP robotic cholecystectomy, hiatal hernia repair with fundoplication, and gastrectomy. With IDE and IRB approval, 12 patients underwent cholecystectomy, hiatal hernia repair with fundoplication and gastrectomy using the single-port surgical platform. All operations were undertaken through a 1.2 cm incision at the umbilicus and the patients who underwent a gastrectomy had an additional 1.2 cm incision for the stapler. Patient perioperative data were collected prospectively. Data is reported as mean ± SD. Five patients underwent SP cholecystectomy for cholelithiasis or biliary dyskinesia. Console time was 172 ± 116.7 min, EBL was minimal. There were no conversions or intraoperative complications. There were no postoperative complications or mortalities. All patients were discharged the same day. Patient #5 was readmitted within 30 days for an aberrant side branch bile duct leak, treated with a percutaneous drain and a stent. Five patients underwent SP hiatal hernia repair with Nissen or Toupet fundoplication for GERD. Console time was 246 ± 16.0 min, EBL was minimal, there were no conversions or intraoperative complications. There were no postoperative complications, mortalities, or readmissions. All patients were discharged the following day. In the second phase, two patients underwent SP gastrectomy, one partial gastrectomy for GIST and one near total gastrectomy with D2 lymphadenectomy for gastric adenocarcinoma, without conversion or perioperative complications. Both had negative margins with adequate lymph node harvest and were discharged on postoperative days 2 and 4 respectively without readmissions. SP cholecystectomy, gastrectomy and hiatal hernia repair with fundoplication are safe and efficacious. Implementation of SP robotic surgery using the da Vinci SP platform lays the groundwork for expanding single-port robotic techniques into advanced foregut and hepatopancreatobiliary (HPB) operations.
- 4 June 2026
- Published by Springer Nature in Surgical Endoscopy
- Vol. 40 (8) , 6577-6584
A prospective, single-center investigation of the single-port robotic platform for cholecystectomy, gastrectomy and anti-reflux operations
Single-port (SP) robotic operations are the next frontier of minimally invasive surgery (MIS), promising to build upon multi-port robotic and laparoscopic techniques. This study aimed to assess the safety and feasibility of SP robotic cholecystectomy, hiatal hernia repair with fundoplication, and gastrectomy. With IDE and IRB approval, 12 patients underwent cholecystectomy, hiatal hernia repair with fundoplication and gastrectomy using the single-port surgical platform. All operations were undertaken through a 1.2 cm incision at the umbilicus and the patients who underwent a gastrectomy had an additional 1.2 cm incision for the stapler. Patient perioperative data were collected prospectively. Data is reported as mean ± SD. Five patients underwent SP cholecystectomy for cholelithiasis or biliary dyskinesia. Console time was 172 ± 116.7 min, EBL was minimal. There were no conversions or intraoperative complications. There were no postoperative complications or mortalities. All patients were discharged the same day. Patient #5 was readmitted within 30 days for an aberrant side branch bile duct leak, treated with a percutaneous drain and a stent. Five patients underwent SP hiatal hernia repair with Nissen or Toupet fundoplication for GERD. Console time was 246 ± 16.0 min, EBL was minimal, there were no conversions or intraoperative complications. There were no postoperative complications, mortalities, or readmissions. All patients were discharged the following day. In the second phase, two patients underwent SP gastrectomy, one partial gastrectomy for GIST and one near total gastrectomy with D2 lymphadenectomy for gastric adenocarcinoma, without conversion or perioperative complications. Both had negative margins with adequate lymph node harvest and were discharged on postoperative days 2 and 4 respectively without readmissions. SP cholecystectomy, gastrectomy and hiatal hernia repair with fundoplication are safe and efficacious. Implementation of SP robotic surgery using the da Vinci SP platform lays the groundwork for expanding single-port robotic techniques into advanced foregut and hepatopancreatobiliary (HPB) operations.
- 28 October 2025
- Published by Springer Nature
- p. 139-150
When and How to Convert During Robotic Pancreaticoduodenectomy
- 28 October 2025
- Published by Springer Nature
- p. 139-150
When and How to Convert During Robotic Pancreaticoduodenectomy
- 11 July 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-10
A decade-long prospective analysis of the learning curve after 435 robotic pancreaticoduodenectomies from a single tertiary institution
Introduction Robotic pancreaticoduodenectomy (PD) has emerged as a leading approach in complex pancreatic surgery, but the path to proficiency is steep. While early learning curve assessments are available for simpler robotic procedures, few studies quantify the extended time and caseload needed to achieve consistency and mastery in robotic PD. Methods With IRB approval, we prospectively followed 435 patients who underwent robotic PD between 2013 and 2024. The learning curve was assessed using Cumulative Sum (CUSUM) analysis based on operative time. Data are presented as median (mean ± SD), and statistical significance was set at p ≤ 0.05. Results CUSUM analysis identified the turning point for consistent procedural proficiency at 88 cases. Patient characteristics included a median age of 70 (68 ± 10.9) years, BMI of 27 (27 ± 5.1) kg/m2, and a predominance of males (54%). A total of 253 patients (58%) had previous abdominal surgery, 36 (8%) had undergone neoadjuvant therapy, and average ASA class and Charlson Comorbidity Index were 3 (± 3) and 5 (± 1.5), respectively. Over time, operative efficiency translated into improved outcomes: unplanned conversions to open surgery declined significantly (p < 0.0001), estimated blood loss decreased (p = 0.04), and hospital stays shortened (p = 0.008). Interestingly, despite growing proficiency, operative times increased (p < 0.0001), reflecting a shift toward more technically demanding cases. A significant rise was also observed in the proportion of patients with prior abdominal surgeries treated after the learning curve milestone (p = 0.007). Conclusions True mastery in robotic PD demands extended experience, with significant procedural gains occurring after the 88-case mark. This extended learning curve should be acknowledged when designing training programs and evaluating surgical outcomes in robotic pancreatic surgery.
- 11 July 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-10
A decade-long prospective analysis of the learning curve after 435 robotic pancreaticoduodenectomies from a single tertiary institution
Introduction Robotic pancreaticoduodenectomy (PD) has emerged as a leading approach in complex pancreatic surgery, but the path to proficiency is steep. While early learning curve assessments are available for simpler robotic procedures, few studies quantify the extended time and caseload needed to achieve consistency and mastery in robotic PD. Methods With IRB approval, we prospectively followed 435 patients who underwent robotic PD between 2013 and 2024. The learning curve was assessed using Cumulative Sum (CUSUM) analysis based on operative time. Data are presented as median (mean ± SD), and statistical significance was set at p ≤ 0.05. Results CUSUM analysis identified the turning point for consistent procedural proficiency at 88 cases. Patient characteristics included a median age of 70 (68 ± 10.9) years, BMI of 27 (27 ± 5.1) kg/m2, and a predominance of males (54%). A total of 253 patients (58%) had previous abdominal surgery, 36 (8%) had undergone neoadjuvant therapy, and average ASA class and Charlson Comorbidity Index were 3 (± 3) and 5 (± 1.5), respectively. Over time, operative efficiency translated into improved outcomes: unplanned conversions to open surgery declined significantly (p < 0.0001), estimated blood loss decreased (p = 0.04), and hospital stays shortened (p = 0.008). Interestingly, despite growing proficiency, operative times increased (p < 0.0001), reflecting a shift toward more technically demanding cases. A significant rise was also observed in the proportion of patients with prior abdominal surgeries treated after the learning curve milestone (p = 0.007). Conclusions True mastery in robotic PD demands extended experience, with significant procedural gains occurring after the 88-case mark. This extended learning curve should be acknowledged when designing training programs and evaluating surgical outcomes in robotic pancreatic surgery.
- 1 June 2025
- Published by Edizioni Minerva Medica in Minerva Surgery
A systematic review assessing the significance of Body Mass Index as a contributing factor of outcomes in patients undergoing complex robotic pancreatic resections
Pancreatic surgeries can be regarded as the most complex and high-risk procedures, with robotic approaches offering improved outcomes. This systematic review aimed to evaluate the impact of Body Mass Index (BMI) on perioperative outcomes in robotic pancreaticoduodenectomy (RPD) and robotic distal pancreatectomy (RDP). Articles published from 2000 to 2024 were sourced from PubMed and Google Scholar using relevant keywords, with inclusion criteria focusing on robotic procedures involving at least 30 patients and BMI classification. Studies using non-robotic approaches were excluded unless used for comparison. Of 17,187 articles identified, 11 met the inclusion criteria. The risk of bias was minimized through dual independent reviewers, adhering to the PRISMA checklist. Overall, 4645 patients (1501 RPD and 3144 RDP cases) were analyzed and highlighted some BMI-associated challenges, including longer operative times and increased postoperative complications in obese patients. However, robotic techniques were found to mitigate some of these issues, demonstrating reduced blood loss, lower conversion rates, and faster recovery compared to open or laparoscopic methods. Results showed that robotic approaches improved surgical safety and efficacy, even in patients with BMI >25 kg/m2, supporting their use in high-risk populations. Despite limited available studies, findings highlight the need for further research on BMI's influence in robotic pancreatic surgeries to optimize patient outcomes and refine clinical practices.
- 1 June 2025
- Published by Edizioni Minerva Medica in Minerva Surgery
A systematic review assessing the significance of Body Mass Index as a contributing factor of outcomes in patients undergoing complex robotic pancreatic resections
Pancreatic surgeries can be regarded as the most complex and high-risk procedures, with robotic approaches offering improved outcomes. This systematic review aimed to evaluate the impact of Body Mass Index (BMI) on perioperative outcomes in robotic pancreaticoduodenectomy (RPD) and robotic distal pancreatectomy (RDP). Articles published from 2000 to 2024 were sourced from PubMed and Google Scholar using relevant keywords, with inclusion criteria focusing on robotic procedures involving at least 30 patients and BMI classification. Studies using non-robotic approaches were excluded unless used for comparison. Of 17,187 articles identified, 11 met the inclusion criteria. The risk of bias was minimized through dual independent reviewers, adhering to the PRISMA checklist. Overall, 4645 patients (1501 RPD and 3144 RDP cases) were analyzed and highlighted some BMI-associated challenges, including longer operative times and increased postoperative complications in obese patients. However, robotic techniques were found to mitigate some of these issues, demonstrating reduced blood loss, lower conversion rates, and faster recovery compared to open or laparoscopic methods. Results showed that robotic approaches improved surgical safety and efficacy, even in patients with BMI >25 kg/m2, supporting their use in high-risk populations. Despite limited available studies, findings highlight the need for further research on BMI's influence in robotic pancreatic surgeries to optimize patient outcomes and refine clinical practices.
- 16 December 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-10
Tampa difficulty score: a scoring system for difficulty of robotic pancreaticoduodenectomy
Robotic platforms are increasingly utilized in surgery, offering unique technical advantages, though there is a scarcity of difficulty scoring systems (DSS) for these procedures. DSS aids in understanding operative complexities and enhancing preoperative planning. With IRB approval, data were collected on 200 consecutive adult patients who underwent robotic pancreaticoduodenectomy at a high-volume institution from 2019 to 2022. Linear regression was employed on clinical variables to analyze operative time and estimated blood loss as markers of surgical complexity. Weighted scoring system was developed using significant linear coefficient values, and an ANOVA analysis created the difficulty-level grouping system. Significant variables affecting operative time and/or EBL included: history of alcoholism, preoperative endoscopic intervention, tumor size, nodal disease on preoperative imaging, pancreatic duct dilation. These factors created the DSS ranging from 0 to 33. Group 1 (0–8, n = 9), Group 2 (9–20, n = 145), Group 3 (21–26, n = 37), and Group 4 (27–33, n = 9) showed significant differences in age, history of alcoholism, preoperative jaundice, tumor size, nodal disease, and operative metrics. Our novel DSS for robotic pancreaticoduodenectomy effectively predicts intraoperative challenges and aids in preoperative planning. Future steps include validating the system internally and externally.
- 16 December 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-10
Tampa difficulty score: a scoring system for difficulty of robotic pancreaticoduodenectomy
Robotic platforms are increasingly utilized in surgery, offering unique technical advantages, though there is a scarcity of difficulty scoring systems (DSS) for these procedures. DSS aids in understanding operative complexities and enhancing preoperative planning. With IRB approval, data were collected on 200 consecutive adult patients who underwent robotic pancreaticoduodenectomy at a high-volume institution from 2019 to 2022. Linear regression was employed on clinical variables to analyze operative time and estimated blood loss as markers of surgical complexity. Weighted scoring system was developed using significant linear coefficient values, and an ANOVA analysis created the difficulty-level grouping system. Significant variables affecting operative time and/or EBL included: history of alcoholism, preoperative endoscopic intervention, tumor size, nodal disease on preoperative imaging, pancreatic duct dilation. These factors created the DSS ranging from 0 to 33. Group 1 (0–8, n = 9), Group 2 (9–20, n = 145), Group 3 (21–26, n = 37), and Group 4 (27–33, n = 9) showed significant differences in age, history of alcoholism, preoperative jaundice, tumor size, nodal disease, and operative metrics. Our novel DSS for robotic pancreaticoduodenectomy effectively predicts intraoperative challenges and aids in preoperative planning. Future steps include validating the system internally and externally.
- 11 December 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-10
An institutional analysis of hospital readmission following a robotic pancreaticoduodenectomy
This study sought to identify the primary reasons for hospital readmissions and examine patient outcomes and associated costs following readmission after robotic pancreaticoduodenectomy. We conducted a retrospective analysis of 435 patients who underwent robotic pancreaticoduodenectomy between 2012 and 2024. Readmitted patients within 30 days post-surgery were compared to non-readmitted patients using Student’s t-test and Fisher’s exact test. Data are presented as median (mean ± SD). In the study cohort, 86 patients (20%) were readmitted within 30 days after surgery. No significant differences were found in patient demographics or outcomes. The most common causes for readmission included insufficient patient education (n = 18), infection (n = 16), and gastrointestinal bleeding (n = 13). The readmitted cohort had significantly higher costs at $40,452 (± 30,724) compared to $31,438 (± 31,546.2) for non-readmitted patients (p < 0.001). Median survival was similar between the two groups (36 vs. 34 months, p = 0.88). Although some readmissions are inevitable, this study provides compelling evidence that inadequate patient education is a primary contributor to increased healthcare costs. The lack of sufficient education appears to have no mitigating effect on patient outcomes. Implementing a proactive, thorough patient education approach, combined with improved emergency department awareness, presents a promising strategy for reducing costly readmissions.
- 11 December 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-10
An institutional analysis of hospital readmission following a robotic pancreaticoduodenectomy
This study sought to identify the primary reasons for hospital readmissions and examine patient outcomes and associated costs following readmission after robotic pancreaticoduodenectomy. We conducted a retrospective analysis of 435 patients who underwent robotic pancreaticoduodenectomy between 2012 and 2024. Readmitted patients within 30 days post-surgery were compared to non-readmitted patients using Student’s t-test and Fisher’s exact test. Data are presented as median (mean ± SD). In the study cohort, 86 patients (20%) were readmitted within 30 days after surgery. No significant differences were found in patient demographics or outcomes. The most common causes for readmission included insufficient patient education (n = 18), infection (n = 16), and gastrointestinal bleeding (n = 13). The readmitted cohort had significantly higher costs at $40,452 (± 30,724) compared to $31,438 (± 31,546.2) for non-readmitted patients (p < 0.001). Median survival was similar between the two groups (36 vs. 34 months, p = 0.88). Although some readmissions are inevitable, this study provides compelling evidence that inadequate patient education is a primary contributor to increased healthcare costs. The lack of sufficient education appears to have no mitigating effect on patient outcomes. Implementing a proactive, thorough patient education approach, combined with improved emergency department awareness, presents a promising strategy for reducing costly readmissions.
- Open Access
- 11 July 2024
- Published by OAE Publishing Inc. in Mini-invasive Surgery
- Vol. 8
Robotic trans-hiatal esophagectomy chapter
- 11 July 2024
- Published by OAE Publishing Inc. in Mini-invasive Surgery
- Vol. 8
Open AccessRobotic trans-hiatal esophagectomy chapter
- 5 July 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 279
Do pre-operative endoscopic procedures, impact the surgical outcomes of robotic pancreaticoduodenectomy?
The role and risks of pre-operative endoscopic procedures, such as endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound with fine needle aspiration (EUS/FNA), in patients undergoing robotic pancreaticoduodenectomy are not well-defined despite a broad consensus on the utility of these interventions for diagnostic and therapeutic purposes prior to major pancreatic operations. This study investigates the impact of such preoperative endoscopic interventions on perioperative outcomes in robotic pancreaticoduodenectomy. With Institutional Review Board (IRB) approval we retrospectively analyzed 772 patients who underwent robotic pancreatectomies between 2012 and 2023. Specifically, 430 of these patients underwent a robotic pancreaticoduodenectomy were prospectively evaluated: 93 (22%) patients underwent ERCP with EUS and FNA, 45 (10%) ERCP only, and 31 (7%) EUS and FNA, while 261 (61%) did not. Statistical analyses were performed using chi-square tests and Student's t-tests to compare perioperative outcomes between the two cohorts. Statistically significant differences were observed in patients who underwent a pre-operative endoscopic intervention and were more likely to have converted to an open operation (p = 0.04). The average number of harvested lymph nodes for patients who underwent preoperative endoscopic intervention was statistically significant compared to those who did not (p = 0.0001). All other perioperative variables were consistent across all cohorts. Patients who underwent endoscopic intervention before robotic pancreaticoduodenectomy were more likely to have an unplanned open operation. This study demonstrates the increased operative difficulties introduced by preoperative endoscopic interventions. Although there was no impact on overall patient outcomes, surgeons' experience can minimize the associated risks.
- 5 July 2024
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 18 (1) , 279
Do pre-operative endoscopic procedures, impact the surgical outcomes of robotic pancreaticoduodenectomy?
The role and risks of pre-operative endoscopic procedures, such as endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound with fine needle aspiration (EUS/FNA), in patients undergoing robotic pancreaticoduodenectomy are not well-defined despite a broad consensus on the utility of these interventions for diagnostic and therapeutic purposes prior to major pancreatic operations. This study investigates the impact of such preoperative endoscopic interventions on perioperative outcomes in robotic pancreaticoduodenectomy. With Institutional Review Board (IRB) approval we retrospectively analyzed 772 patients who underwent robotic pancreatectomies between 2012 and 2023. Specifically, 430 of these patients underwent a robotic pancreaticoduodenectomy were prospectively evaluated: 93 (22%) patients underwent ERCP with EUS and FNA, 45 (10%) ERCP only, and 31 (7%) EUS and FNA, while 261 (61%) did not. Statistical analyses were performed using chi-square tests and Student's t-tests to compare perioperative outcomes between the two cohorts. Statistically significant differences were observed in patients who underwent a pre-operative endoscopic intervention and were more likely to have converted to an open operation (p = 0.04). The average number of harvested lymph nodes for patients who underwent preoperative endoscopic intervention was statistically significant compared to those who did not (p = 0.0001). All other perioperative variables were consistent across all cohorts. Patients who underwent endoscopic intervention before robotic pancreaticoduodenectomy were more likely to have an unplanned open operation. This study demonstrates the increased operative difficulties introduced by preoperative endoscopic interventions. Although there was no impact on overall patient outcomes, surgeons' experience can minimize the associated risks.